• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,918.76 394.50
( 0.54%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Wanbury Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524212
INE107F01022
41.3428411
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WANBURY
12.66
882.57
EPS(TTM)
Face Value()
Div & Yield %
19.95
10
0
 

NTPC consolidated net profit rises 37.78% in the March 2026 quarter
May 23,2026
Net profit of NTPC rose 37.78% to Rs 10486.47 crore in the quarter ended March 2026 as against Rs 7611.22 crore during the previous quarter ended March 2025. Sales declined 0.29% to Rs 49687.77 crore in the quarter ended March 2026 as against Rs 49833.70 crore during the previous quarter ended March 2025.

For the full year,net profit rose 15.50% to Rs 27052.52 crore in the year ended March 2026 as against Rs 23422.46 crore during the previous year ended March 2025. Sales declined 0.40% to Rs 187384.63 crore in the year ended March 2026 as against Rs 188138.06 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales49687.7749833.70 0 187384.63188138.06 0
OPM %17.1229.61 -28.1928.77 -
PBDT6686.6315285.85 -56 44298.6749599.52 -11
PBT1552.8410622.78 -85 24669.3432198.33 -23
NP10486.477611.22 38 27052.5223422.46 15